Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Applied Clinical Trials, July/August 2019 Issue (PDF)

Articles in this issue

Related Content

Why Four Regulatory Scenarios Could De-Risk Selective Safety Data Collection

NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market

ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value

Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors

Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle

Trending on Applied Clinical Trials Online

NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market

Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors

ACT Brief: DIA Leadership and Infrastructure Priorities, Real-Time Data Review Readiness, and CLL Treatment Expansion

Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle

ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value